Anti-proliferative effect of estrogen in breast cancer cells that re-express ERα is mediated by aberrant regulation of cell cycle genes

Journal of Molecular Endocrinology

Volumn 34, Issue 2, 2005, Pages 535-551

  Moggs, Jonathan G ^a   Murphy, T C ^a   Lim, F L ^a   Moore, D J ^a   Stuckey, R ^a   Antrobus, K ^a   Kimber, I ^a   Orphanides, G ^a  

^a JEALOTT S HILL INTERNATIONAL RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUB3 PROTEIN; CHECKPOINT KINASE 1; COMPLEMENTARY DNA; CYCLIN B1; CYCLIN B2; CYCLIN DEPENDENT KINASE 1; CYCLIN G1; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; MINICHROMOSOME MAINTENANCE PROTEIN 2; PROTEIN P57; PROTEIN PS2; SURVIVIN; UVOMORULIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE PARAMETERS; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENETIC CODE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, CDC; GENES, REPORTER; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 17844386351     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.1.01677     Document Type: Article

References (47)

1. Bard JB & Rhee SY 2004 Ontologies in biology: design, applications and future challenges. Nature Reviews Genetics 5 213-222.
2. Benjamini Y & Hochberg Y 1995 Controlling the False Discovery Rate: a Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Sociey: Series B 57 289-300.
3. Berry M, Nunez AM & Chambon P 1989 Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. PNAS 86 1218-1222.
4. Blow JJ & Hodgson B 2002 Replication licensing - defining the proliferative state? Trends in Cell Biology 12 72-78.
5. Bourdeau V, Deschenes J, Metivier R, Nagai Y, Nguyen D, Bretschneider N, Gannon F, White JH & Mader S 2004 Genome-wide identification of high-affinity estrogen response elements in human and mouse. Molecular Endocrinology 18 1411-1427.
6. Coppock DL, Cina-Poppe D & Gilleran S 1998 The quiescin Q6 gene (QSCN6) is a fusion of two ancient gene families: thioredoxin and ERV1. Genomics 54 460-468.
7. van der Burg B, van Selm-Miltenburg AJ, de Laat SW & van Zoelen EJ 1989 Direct effects of estrogen on c-fos and c-myc protooncogene expression and cellular proliferation in human breast cancer cells. Molecular and Cellular Endocrinology 64 223-228.
8. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC & Conklin BR 2002 GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nature Genetics 31 19-20.
9. Davidson NE, Bronzert DA, Chambon P, Gelmann EP & Lippman ME 1986 Use of two MCF-7 cell variants to evaluate the growth regulatory potential of estrogen-induced products. Cancer Research 46 1904-1908.
10. Ferguson AT, Lapidus RG, Baylin SB & Davidson NE 1995 Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. Cancer Research 55 2279-2283
11. Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR & Katzenellenbogen BS 2003 Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144 4562-4574.
12. Fujita N, Jaye DL, Kajita M, Geigerman C, Moreno CS & Wade PA 2003 MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 113 207-219.
13. Garcia M, Derocq D, Freiss G & Rochefort H 1992 Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells. PNAS 89 11538-11542.
14. GEO 2004 Gene Expression Omnibus Homepage, Bethesda, MD: National Center for Biotechnology Information, National Library of Medicine, Available: http://www.ncbi.nlm.nih.gov/geo/.
15. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P & Chambon P 1986 Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320 134-139.
16. Hall JM, Couse JF & Korach KS 2001 The multifaceted mechanisms of estradiol and estrogen receptor signaling. Journal of Biological Chemistry 276 36869-36872.
17. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW & Vogelstein B 1998 A simplified system for generating recombinant adenoviruses. PNAS 95 2509-2514.
18. Klinge CM 2001 Estrogen receptor interaction with estrogen response elements. Nucleic Acids Research 9 2905-2919.
19. Kobayashi K, Hatano M, Otaki M, Ogasawara T & Tokuhisa T 1999 Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation. PNAS 96 1457-1462.
20. Laborda J 1991 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein P0. Nucleic Acids Research 19 3998.
21. Lazennec G & Katzenellenbogen BS 1999 Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells. Molecular and Cellular Endocrinology 149 93-105.
22. Levenson AS & Jordan C 1994 Transfection of Human Estrogen Receptor (ER) cDNA into ER-negative Mammalian Cell Lines. Journal of Steroid Biochemistry and Molecular Biology 51 229-239.
23. Levenson AS, Svoboda KM, Pease KM, Kaiser SA, Chen B, Simons LA, Jovanovic BD, Dyck PA & Jordan VC 2002 Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor. Cancer Research 62 4419-4426.
24. Liu G, Loraine AE, Shigeta R, Cline M, Cheng J, Valmeekam V, Sun S, Kulp D & Siani-Rose MA 2003 NetAffx: Affymetrix probesets and annotations. Nucleic Acids Research 31 82-86
25. Lobenhofer EK, Bennett L, Cable PL, Li L, Bushel PR & Afshari CA 2002 Regulation of DNA replication fork genes by 17 beta-estradiol. Molecular Endocrinology 16 1215-1229.
26. McKenna NJ & O'Malley BW 2002 Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108 465-474
27. Menard S, Pupa SM, Campiglio M & Tagliabue E 2003 Biologic and therapeutic role of HER2 in cancer. Oncogene 22 6570-6578.
28. Moggs JG & Orphanides G 2001 Estrogen receptors: orchestrators of pleiotropic cellular responses. EMBO Reports 2 775-781.
29. Murphy TC & Orphanides G 2002 Characterisation of the molecular responses to xenoestrogens using gene expression profiling. Phytochemistry Reviews 1 199-208.
30. Oesterreich S, Deng W, Jiang S, Cui X, Ivanova M, Schiff R, Kang K, Hadsell DL, Behrens J & Lee AV 2003 Estrogen-mediated Down-regulation of E-cadherin in Breast Cancer Cells. Cancer Research 63 5203-5208.
31. Ottaviano YL, Issa JP, Parl FF, Smith HS, Baylin SB & Davidson NE 1994 Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Research 54 2552-2555.
32. Ozaki T, Nakamura Y, Enomoto H, Hirose M & Sakiyama S 1995 Overexpression of DAN gene product in normal rat fibroblasts causes a retardation of the entry into the S phase. Cancer Research 55 895-900.
33. Philips A, Teyssier C, Galtier F, Rivier-Covas C, Rey JM, Rochefort H & Chalbos D 1998 FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells. Molecular Endocrinology 12 973-985.
34. Pike MC, Spicer DV, Dahmoush L & Press MF 1993 Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiologic Reviews 15 17-35.
35. Prall OW, Sarcevic B, Musgrove EA, Watts CK & Sutherland RL 1997 Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. Journal of Biological Chemistry 272 10882-10894.
36. Reed SI 2003 Ratchets and clocks: the cell cycle, ubiquitylation and protein turnover. Nature Reviews Molecular Cell Biology 4 855-864.
37. Rochefort H, Glondu M, Sahla ME, Platet N & Garcia M 2003 How to target estrogen receptor-negative breast cancer? Endocrine Related Cancer 10 261-266.
38. Sambrook J, Fritsch EF & Maniatis T 1989 Molecular Cloning: A Laboratory Manual, 2nd edition. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
39. Shang Y & Brown M 2002 Molecular determinants for the tissue specificity of SERMs. Science 295 2380-2381.
40. Tanaka T, Dancheck BL, Trifiletti LC, Birnkrant RE, Taylor BJ, Garfield SH, Thorgeirsson U & De Luca LM 2004 Altered localization of retinoid X receptor alpha coincides with loss of retinoid responsiveness in human breast cancer MDA-MB-231 cells. Molecular and Cellular Biology 24 3972-3982.
41. Thiery JP 2002 Epithelial-mesenchymal transitions in tumour progression. Nature Reviews Cancer 2 442-454.
42. Tremblay GB & Giguere V 2002 Coregulators of estrogen receptor action. Critical Reviews in Eukaryotic Gene Expression 12 1-22
43. Vodermaier HC 2001 Cell cycle: Waiters serving the Destruction machinery. Current Biology 11 R834-R837.
44. Vogel VG & Lo S 2003 Preventing hormone-dependent breast cancer in high-risk women. Journal of the National Cancer Institute 95 91-93.
45. Weisz A, Cicatiello L, Persico E, Scalona M & Bresciani F 1990 Estrogen stimulates transcription of c-jun protooncogene. Molecular Endocrinology 4 1041-1050.
46. Yang X, Ferguson AT, Nass SJ, Phillips DL, Butash KA, Wang SM, Herman JG & Davidson NE 2000 Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition. Cancer Research 60 6890-6894.
47. Yang X, Phillips DL, Ferguson AT, Nelson WG, Herman JG & Davidson NE 2001 Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. Cancer Research 61 7025-7029.